Published in Medical Letter on the CDC and FDA, July 25th, 2004
The agency's first assignment from Cumberland - a 5-year-old pharmaceutical company located in Nashville, Tennessee - was the January 2004 launch of CeraLyte, a treatment for both dehydration and diarrhea. The new drug, called Acetadote (acetylcysteine) Injection received U.S. Food and Drug Administration (FDA) approval in January of this year.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA